KYSENSE unveils new KOL

07 Sep 2021

Hyaluronic acid dermal filler company KYSENSE has announced consultant plastic and reconstructive surgeon Mr David Gateley as its new key opinion leader (KOL).

Mr Gateley will be one of the key injectors in the next KYSENSE clinical trial at the clinical research organisation in Lyon, starting on September 14.

KYSENSE explains that the trial will collect data to present to the Medical Device Regulation (MDR) for CE marking. Mr Gateley will be helping to develop training and techniques for KYSENSE as part of his role.

Mr Gateley said, “I’m delighted to be a KOL for KYSENSE. The quality of the product through the science is unparalleled and therefore the characteristics meet all the requirements of a non-permanent injectable filler for the face.” 


Log-in to post a comment